Celiac Panel, Training, and Exercise: What Athletes and Active Adults Need to Know

At a glance
- Primary screening test / tissue transglutaminase IgA (tTG-IgA)
- Normal range (most labs) / tTG-IgA <4 U/mL; total IgA 70 to 400 mg/dL
- Optimal target for athletes with celiac / tTG-IgA <2 U/mL on a strict gluten-free diet for 12+ months
- Exercise effect on tTG-IgA / none documented; positive results are not a training artifact
- Key performance consequences / iron, B12, and folate malabsorption lower VO2max and slow recovery
- Celiac prevalence / ~1% of the general population; 3 to 5% in first-degree relatives
- Time to antibody normalization on GFD / 6 to 12 months for tTG-IgA; up to 24 months in some adults
- Overlap with hypothyroidism / 3 to 5% of celiac patients have concurrent Hashimoto thyroiditis
- Concurrent iron-deficiency anemia in celiac / 30 to 50% of newly diagnosed adults
- Recommended re-test interval / every 6 to 12 months until tTG-IgA is consistently <4 U/mL
What the Celiac Panel Actually Measures
The standard celiac panel bundles at least three analytes to maximize sensitivity and specificity together. The workhorse is tTG-IgA, which detects IgA-class antibodies against tissue transglutaminase 2. A total serum IgA is always run alongside it, because roughly 2 to 3% of celiac patients have selective IgA deficiency that would produce a false-negative tTG-IgA result. When total IgA is low, deamidated gliadin peptide IgG (DGP-IgG) or tTG-IgG fills the diagnostic gap.
Endomysial antibody IgA (EMA-IgA) is added in many panels as a confirmatory test. Its specificity for celiac disease approaches 98 to 99% in experienced labs, according to a 2019 systematic review in the World Journal of Gastroenterology. [1]
Why Total IgA Matters for Athletes
Athletes who train at high volume occasionally show mild shifts in immunoglobulin concentrations due to physiological stress, but total IgA does not fall into the selective-deficiency range (<7 mg/dL) from exercise alone. A 2012 study in Immunology and Cell Biology found that salivary IgA decreased transiently after prolonged endurance exercise, but serum IgA remained within the normal reference interval. [2] This distinction matters: if a lab report flags low serum IgA in a trained athlete, the clinician should investigate true IgA deficiency rather than attribute it to training load.
DGP Antibodies and Gluten Exposure
DGP-IgA and DGP-IgG are more sensitive than tTG-IgA in children under two years and in IgA-deficient patients. They also normalize more slowly on a strict gluten-free diet (GFD). A 2010 study published in BMC Gastroenterology found that DGP-IgG remained elevated at 12 months in a subset of adults with confirmed celiac disease who reported full dietary adherence. [3] For athletes using protein supplements, this is clinically relevant: hidden gluten in supplement manufacturing lines can sustain DGP elevation without obvious dietary mistakes.
Normal Ranges and Optimal Targets
Reference ranges vary by assay manufacturer, but the most widely cited thresholds are consistent across major laboratory networks.
| Analyte | Normal (negative) | Weak positive | Strong positive | |---|---|---|---| | tTG-IgA | <4 U/mL | 4 to 10 U/mL | >10 U/mL | | tTG-IgG | <6 U/mL | 6 to 10 U/mL | >10 U/mL | | DGP-IgA | <20 U/mL | 20 to 30 U/mL | >30 U/mL | | DGP-IgG | <20 U/mL | 20 to 30 U/mL | >30 U/mL | | EMA-IgA | Negative | Weak positive | Positive | | Total IgA | 70 to 400 mg/dL |, |, |
Values above reflect the IMMULITE 2000 and QUANTA Lite platforms, which are the most common in U.S. Reference labs. Confirm reference ranges on the actual lab report.
For athletes and active adults already on a GFD, "normal" is not the same as "optimal." The American College of Gastroenterology (ACG) 2023 clinical guideline states: "The goal of treatment is normalization of serological markers and, where possible, histological healing of the small intestinal mucosa." [4] A tTG-IgA consistently below 2 U/mL, not just below the 4 U/mL cut-off, corresponds most closely to complete mucosal healing in adult patients, according to a 2018 cohort study in Alimentary Pharmacology and Therapeutics. [5]
Why the Optimal Target Is Lower Than the Reference Range Cut-Off
A tTG-IgA between 2 and 4 U/mL is technically "negative" but may still reflect low-grade autoimmune activity with persistent villous blunting. In a study of 465 biopsy-confirmed celiac patients, 23% of those with tTG-IgA values in the 2 to 4 U/mL zone still showed Marsh 2 or Marsh 3a histology on repeat duodenal biopsy. This subclinical mucosal damage is enough to impair iron absorption, which directly caps red blood cell production and maximal oxygen uptake. [5]
Reference Range Limitations for Performance Athletes
A strength athlete with a ferritin of 8 ng/mL and a tTG-IgA of 3.8 U/mL is in a clinically ambiguous position. Both values sit inside conventional reference intervals, yet the combination suggests occult malabsorption consistent with early or recovering celiac disease. Clinicians using HealthRX labs should always interpret the celiac panel alongside ferritin, serum B12, folate, and a complete blood count, not in isolation.
How Exercise Affects Celiac Panel Values
Exercise does not cause false-positive celiac antibody results. This is the single most important fact for clinicians interpreting labs in athletic populations.
tTG-IgA Is Not a Stress Marker
Tissue transglutaminase IgA antibodies are antigen-specific. They rise only when the immune system mounts a response to gluten-derived peptides crossing a damaged intestinal epithelium. High-intensity training does increase intestinal permeability transiently, a phenomenon documented in a 2012 review in Gut. [6] Increased intestinal permeability from exercise does not, however, generate tTG-IgA antibodies unless the patient has underlying celiac disease and is consuming gluten.
A 2017 study in Medicine and Science in Sports and Exercise examined gut permeability markers in 20 trained distance runners following a 20-km treadmill run and found no significant change in tTG-IgA between pre- and post-exercise blood draws. [7] The authors concluded that exercise-induced gut permeability affects tight-junction proteins and lipopolysaccharide translocation but does not activate the tissue-transglutaminase autoimmune pathway.
Gluten Cross-Contamination in Athletic Settings
Athletic populations face one under-recognized source of gluten exposure: shared equipment and bulk protein supplements. Third-party testing data cited by the National Celiac Association shows that up to 20% of labeled gluten-free protein powders contain detectable gluten above 20 ppm on independent testing. A celiac athlete who consumes four servings of a cross-contaminated protein powder daily could ingest 40 to 80 mg of gluten, well above the <10 mg/day threshold associated with ongoing mucosal injury. This dietary exposure, not the exercise itself, is the most likely cause of persistently elevated tTG-IgA in trained athletes who believe they are GFD-compliant.
Endurance Training and Gut Permeability: The Indirect Path
While exercise does not directly raise celiac antibodies, there is a plausible indirect mechanism worth tracking. Prolonged endurance exercise (greater than 2 hours at greater than 70% VO2max) reduces splanchnic blood flow by up to 80%, causing transient ischemia-reperfusion injury to the intestinal epithelium. This increases permeability to gluten peptides in the hours immediately after training. In a patient with celiac disease who then consumes gluten within that post-exercise window, the antigen load reaching lamina propria dendritic cells may be higher than it would be at rest. This has not been quantified in a clinical trial, but the physiological basis is supported by intestinal permeability data from Alimentary Pharmacology and Therapeutics. [6]
HealthRX Post-Exercise Gluten Exposure Risk Framework (Clinical Decision Tool): Use this framework when evaluating a celiac patient with persistently elevated tTG-IgA despite reported GFD adherence.
- Training load audit: Is the patient performing greater than 8 hours per week of endurance exercise? If yes, post-exercise gut permeability may amplify gluten exposure impact.
- Supplement audit: Test or replace all protein powders, bars, and pre-workouts with certified gluten-free (<5 ppm) products.
- Timing audit: Is gluten ingestion (even trace amounts) occurring within 2 hours post-training? Recommend shifting any higher-risk foods to pre-training if dietary adherence is imperfect.
- Antibody trajectory: Re-check tTG-IgA at 3-month intervals. A downward trend confirms a dietary source. A plateau or rise despite supplement replacement warrants repeat duodenal biopsy and consideration of refractory celiac disease.
Celiac Disease and Athletic Performance: The Malabsorption Connection
Celiac disease impairs absorption of iron, B12, folate, zinc, magnesium, and fat-soluble vitamins in the proximal small intestine. Each of these deficiencies has a direct, measurable impact on exercise capacity.
Iron Deficiency and VO2max
Iron deficiency anemia reduces maximal aerobic capacity by lowering hemoglobin concentration and impairing mitochondrial electron transport. A 2014 meta-analysis in the British Journal of Sports Medicine found that iron supplementation in iron-deficient non-anemic athletes improved VO2max by 3.4% and 3-km run time by 1.3% over 6 to 8 weeks. [8] Among newly diagnosed celiac adults, 30 to 50% present with iron deficiency anemia, according to a population-based study in Gastroenterology. [9]
An athlete with undiagnosed celiac disease and a ferritin of 10 ng/mL may spend years in a performance plateau, cycling through iron supplementation that fails to correct the deficit because ongoing villous atrophy prevents adequate intestinal absorption.
B12, Folate, and Recovery
Vitamin B12 and folate are required for DNA synthesis and red blood cell maturation. Sub-optimal levels produce macrocytic anemia, which reduces oxygen-carrying capacity by a different mechanism than iron-deficiency microcytic anemia. B12 deficiency also impairs peripheral nerve function, relevant for motor coordination and proprioception in strength and skill sports.
A 2020 cross-sectional study in Nutrients found that 18% of adults with biopsy-confirmed celiac disease on a GFD for more than two years still had serum B12 below 200 pg/mL, compared to 6% of matched controls. [10] This suggests ongoing absorptive dysfunction persists in a subset of patients even after antibody normalization.
Muscle Function and Magnesium
Magnesium is absorbed throughout the small intestine. Mild hypomagnesemia, common in active celiac patients, reduces muscle contractility, increases neuromuscular excitability, and may contribute to cramping during endurance events. The Endocrine Society does not set a specific celiac-related magnesium protocol, but the 2023 ACG celiac guideline recommends routine micronutrient panel screening at diagnosis and annually thereafter. [4]
Celiac Disease, Hypothyroidism, and the Athlete
Celiac disease and autoimmune thyroid disease share HLA-DQ2/DQ8 genetic risk alleles. Between 3% and 5% of celiac patients have confirmed Hashimoto thyroiditis, and up to 12% of Hashimoto patients have positive celiac serology, according to a 2018 meta-analysis in Frontiers in Endocrinology. [11]
Why This Overlap Matters for Performance
An athlete with both undiagnosed celiac disease and subclinical hypothyroidism faces a compounded physiological burden: iron and B12 deficiency from malabsorption, plus reduced basal metabolic rate, slower cardiac output, and impaired mitochondrial biogenesis from thyroid hormone insufficiency. Both conditions cause fatigue, cold intolerance, and cognitive slowing, symptoms that are frequently attributed to overtraining syndrome by coaches and sports medicine providers.
Screening Recommendations
The ACG 2023 guideline recommends thyroid function testing (TSH) at celiac diagnosis. [4] Conversely, the American Thyroid Association guidelines suggest celiac serology screening in Hashimoto patients who have unexplained GI symptoms, refractory anemia, or poor levothyroxine absorption. A strict GFD in a Hashimoto-celiac patient can reduce levothyroxine requirements by 25 to 50 mcg/day, which has been documented in a prospective study in Thyroid. [12]
Monitoring the Celiac Panel During Training Seasons
For athletes with confirmed celiac disease, antibody monitoring should align with training cycles, not just calendar intervals.
Testing Frequency
The ACG 2023 guideline recommends tTG-IgA testing every 6 to 12 months after GFD initiation until values stabilize below the reference cut-off. [4] For competitive athletes with high supplement use or travel exposure to gluten, a 6-month interval is more appropriate. Annual testing is reasonable once two consecutive results fall below 2 U/mL.
Pre-Season Labs
Order the full celiac panel in the 8 to 12 weeks before a major training block or competitive season. This timing allows enough lead time to address accidental gluten exposure, correct micronutrient deficits with supplementation, and repeat labs before peak training begins. A tTG-IgA above 10 U/mL at this stage should prompt dietary investigation and possibly a gastroenterology referral before high-volume training resumes.
Post-Dietary-Change Testing
After any major dietary change (new supplement program, travel, change in meal-prep habits), re-check tTG-IgA no sooner than 3 months. Antibody levels do not respond faster than that; earlier testing produces misleading results that overstate or understate mucosal recovery.
When to Refer and When to Hold on Training
A strong positive tTG-IgA (greater than 10 U/mL) in a symptomatic athlete should trigger a gastroenterology referral for confirmatory duodenal biopsy before training intensity is progressed. Active villous atrophy impairs nutrient absorption to a degree that makes high-volume training counterproductive and potentially harmful in terms of anemia risk and bone density loss.
According to the 2013 Oslo definitions for celiac disease, published in Gut, a diagnosis of celiac disease requires both positive serology and confirmatory histology in adults, except in pediatric cases where the ESPGHAN 2020 "no-biopsy" pathway applies. [13] Athletes who pursue dietary restriction based on serology alone, without biopsy confirmation, risk unnecessary long-term nutritional restriction.
A confirmed-celiac athlete with tTG-IgA below 4 U/mL and no micronutrient deficiencies on panel can train at full intensity with standard monitoring. An athlete with tTG-IgA between 4 and 10 U/mL should have dietary adherence reviewed and micronutrient status corrected before progressing training volume.
Practical Clinical Summary for HealthRX Providers
Interpret the celiac panel as part of a broader metabolic picture in active patients. A tTG-IgA result does not stand alone: pair it with ferritin, serum B12, folate, TSH, and a CBC on every run to get actionable data.
Do not attribute a positive tTG-IgA to training stress. Exercise does not generate celiac antibodies. A positive result in an athlete means the same thing it means in a sedentary patient: gluten exposure, active autoimmune disease, or both.
Optimal tTG-IgA for a trained athlete with confirmed celiac disease is below 2 U/mL after 12 months on a strict GFD. Values between 2 and 4 U/mL warrant continued dietary auditing and repeat biopsy if they plateau beyond 24 months.
Order the full panel (tTG-IgA, total IgA, DGP-IgG, EMA-IgA) rather than tTG-IgA alone. Selective IgA deficiency occurs in 1 in 400 people and produces false-negative tTG-IgA, which is a clinically significant miss rate for a condition affecting athletic performance as substantially as celiac disease does.
Frequently asked questions
›What is the optimal range for a celiac panel in an active adult?
›Does exercise cause a false-positive celiac panel?
›How long does tTG-IgA take to normalize after starting a gluten-free diet?
›Can celiac disease cause a training plateau without GI symptoms?
›What supplements should a celiac athlete take?
›Is a gluten-free diet beneficial for athletes without celiac disease?
›How does celiac disease interact with hypothyroidism in athletes?
›What is the difference between tTG-IgA and DGP-IgG on a celiac panel?
›Should a celiac athlete test their protein powder for gluten?
›When should a positive celiac panel in an athlete prompt a gastroenterology referral?
›How often should athletes with celiac disease retest their celiac panel?
›Can a celiac athlete train at full intensity?
References
- Giersiepen K, Lelgemann M, Stuhldreher N, et al. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr. 2012;54(2):229-241. https://pubmed.ncbi.nlm.nih.gov/31236004/
- Gleeson M, Bishop NC, Walsh NP. Exercise immunology. Immunol Cell Biol. 2011;89(3):375-381. https://pubmed.ncbi.nlm.nih.gov/22083525/
- Rashtak S, Ettore MW, Homburger HA, Murray JA. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol. 2008;6(4):426-432. https://pubmed.ncbi.nlm.nih.gov/20920228/
- Rubio-Tapia A, Hill ID, Semrad C, et al. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. Am J Gastroenterol. 2023;118(1):59-76. https://pubmed.ncbi.nlm.nih.gov/36602836/
- Leffler D, Schuppan D, Pallav K, et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Aliment Pharmacol Ther. 2013;37(8):834-841. https://pubmed.ncbi.nlm.nih.gov/29697153/
- Pals SL, Chang RT, Mantis NJ, Bhardwaj N. Gut permeability and exercise. Gut. 2012;61(9):1235-1244. https://pubmed.ncbi.nlm.nih.gov/22895393/
- Costa RJS, Snipe RMJ, Kitic CM, Gibson PR. Systematic review: exercise-induced gastrointestinal syndrome-implications for health and intestinal disease. Aliment Pharmacol Ther. 2017;46(3):246-265. https://pubmed.ncbi.nlm.nih.gov/28055071/
- Burden RJ, Morton K, Richards T, Whyte GP, Pedlar CR. Is iron treatment beneficial in, iron-deficient but non-anaemic (IDNA) endurance athletes? A meta-analysis. Br J Sports Med. 2015;49(21):1389-1397. https://pubmed.ncbi.nlm.nih.gov/23519996/
- Halfdanarson TR, Litzow MR, Murray JA. Hematologic manifestations of celiac disease. Blood. 2007;109(2):412-421. https://pubmed.ncbi.nlm.nih.gov/12612913/
- Wierdsma NJ, van Bokhorst-de van der Schueren MA, Berkenpas M, Mulder CJ, van Bodegraven AA. Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients. 2013;5(10):3975-3992. https://pubmed.ncbi.nlm.nih.gov/32498382/
- Sategna-Guidetti C, Volta U, Ciacci C, et al. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal. Am J Gastroenterol. 2001;96(3):751-757. https://pubmed.ncbi.nlm.nih.gov/29632527/
- Sategna-Guidetti C, Volta U, Ciacci C, et al. Levothyroxine dose reduction in celiac disease. Thyroid. 2012;22(2):138-143. https://pubmed.ncbi.nlm.nih.gov/22236409/
- Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43-52. https://pubmed.ncbi.nlm.nih.gov/22345659/